Blood transfusion saves lives and reduces morbidity and mortality for a large number of diseases and clinical conditions, but it is not without danger. The aim of this study was to determine the seroprevalence of HIV and hepatitis B in blood donors received at the regional Blood Transfusion Centre of N’Zérékoré (Guinea). This was a 5-year retrospective analytical study. We included records of blood donors aged 18 to 60 years admitted to the N’Zérékoré Regional Blood Transfusion Centre for blood donation from January 2016 to December 2020. We performed a descriptive analysis followed by Chi-2 or Fish-er-exact tests and the Student or Wilcoxon test, followed by multivariate logistic regression. In this study, donor age ranged from 18 - 60 years, with a pre-dominance of donors aged 25 - 34 (44.2%). Male donors were the most represented in our study (79.0% versus 21.0% female). More than half of the donors were blood group O (55.6%). We observed a seroprevalence of 3.6% for HIV, 13.4% for HBsAg and 0.2% for co-infection. In our series, age 25 - 34 (OR = 1.89 and P = 0.001) and 35 - 44 for HIV (OR = 2.01 and P = 0.001), HBsAgserostatus (OR = 3.04 and P = 0.001) and blood donation history (OR of 3.04 and P = 0.001) were factors associated with HIV positivity (P < 0.05). In our study, HIV serostatus (OR = 3.04 and P = 0.001) and blood donation history (OR = 0.01 and P = 0.001) were factors associated with HBsAgseropositivity. We reported a high prevalence of HIV and HBsAg. Sex, serological status and blood donation history were associated factors.
References
[1]
Agence de la santé publique Canada (2002) Incidents Transfusionnels (IT). https://www.canada.ca/fr/sante-publique/services/surveillance/programme-contributions-surete-sang/section-incidents-transfusionnels/risques.html
[2]
Kakisingi, C.N., Mukuku, O., Matanda, S.K., Manika, M.M., Kyabu, V.K., Kasamba, E.I., et al. (2016) Profil épidémiologique et séroprévalence des donneurs de sang aux cliniques universitaires de Lubumbashi, République Démocratique du Congo. Pan African Medical Journal, 23, Article 175. https://doi.org/10.11604/pamj.2016.23.175.8480
[3]
OMS (2023) Sécurité transfusionnelle et approvisionnement en sang. https://www.who.int/fr/news-room/fact-sheets/detail/blood-safety-and-availability
[4]
Fohoue, A.M., Sack, F.N., Fossi, C.T., Fossi, A. and Bassong, Y.O.M. (2019) Prévalence des Infections Transmissibles par Transfusion Sanguine chez les Donneurs de Sang à l’Hôpital Central de Yaoundé—Cameroun. Health Sciences and Diseases, 20, 23-28.
[5]
Sarr, H., Mayaki, Z., Dardenne, N., Kabo, R., Moutschen, M., Sondag, D., Albert, A., Gérard, C., et al. (2021) Séroprévalence des Marqueursd’AgentsInfectieux (VIH, VHB, VHC et Syphilis) chez les Donneurs de Sang à Ziguinchor. Health Sciences and Diseases, 22, 81-84.
[6]
Cissé, M. (2020) La Séroprévalence des marqueursbiologiques chez les donneurs de sang de Janvier à Décembre 2018 au Centre HospitalierUniversitaire de Gabriel Toure. Master’s Thesis, Université des Sciences, des Techniques et des Technologies de Bamako.
[7]
Loua, A., M.L. Sow, E., Magassouba, F.B., Camara, M. and Baldé, M.A. (2004) Évaluation du risque infectieux résiduel chez les donneurs de sang au Centre national de transfusion sanguine de Conakry. Transfusion Clinique et Biologique, 11, 98-100. https://doi.org/10.1016/j.tracli.2004.01.004
[8]
Comité National de LutteContre le, Sida (2012) Rapport annuel de la Riposte Nationale aux IST/VIH/SidaGuinée.
[9]
Packo, D.S.S., Tomlbaye, F.O., Conde, A., Diakité, M., Kouandogui, F. and Camengo-Police, S.M. (2022) CaractéristiquesÉpidémiologiques et Cliniques des Donneurs de Sang Co-Infectés par les Virus VIH et VHB au Centre National de Transfusion Sanguine de Bangui. Health Sciences and Diseases, 23, 46-48.
[10]
Chigurupati, P. and Murthy, K.S. (2015) Automated Nucleic Acid Amplification Testing in Blood Banks: An Additional Layer of Blood Safety. Asian Journal of Transfusion Science, 9, 9-11. https://doi.org/10.4103/0973-6247.150938
[11]
Mbanya, D. (2013) Use of Quality Rapid Diagnostic Testing for Safe Blood Transfusion in Resource-Limited Settings. Clinical Microbiology and Infection, 19, 416-421. https://doi.org/10.1111/1469-0691.12184
[12]
Robertson, C., Archibald, D., et al. (2014) Systematic Reviews and Integrated Report on the Quantitative, Qualitative and Economic Evidence Base for the Management of Obesity in Men. Health Technol Assess, 18, 458p. https://doi.org/10.3310/hta18350
[13]
Goita, D., Traore, M., Kassogue, O., Sogoba, D., Guindo, S., Keita, B.S., et al. (2019) Séroprévalence du VIH, des Virus des Hépatites B et C et de la Syphilis chez les Donneurs de Sang à l’Hôpital de Sikasso, Mali. Health Sciences and Diseases, 20, 43-46.
[14]
Koné, M.C., Sidibé, E.T., Mallé, K.K., Beye, S.A., Lurton, G., Dao, S., et al. (2012) Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus and Hepatitis C Virus among Blood Donors in Segou, Mali. Médecine et Santé Tropicales, 22, 97-98. https://doi.org/10.1684/mst.2012.0016
[15]
Diarra, A.B., Guitteye, H., Fomba, M., Cisse, M., Traore, D., Traore, A., et al. (2019) Viral Hepatitis B and C in Blood Donors of the National Blood Transfusion Center Bamako, Mali. Revue Malienne d’Infectiologie et de Microbiologie, 14, 58-61.
[16]
Katilé, D., Konaté, I., Goita, D., Kaboré, M., Dicko, M.Y., Mallé, O., Kondé, A., et al. (2018) Prévalence de l’Antigène HBs et ProfilSérologique du Virus de l’Hépatite B en Consultation de Médecine Générale à l’HôpitalRégional de Kayes au Mali 2018. Health Sciences and Diseases, 19, 16-19.
[17]
Mudji, J., Malala, J. and Horsmans, Y. (2021) Seroprevalence of Viral Hepatitis B and C in Two Populations: Blood Donors and Patients with Suspected Hepatic Cirrhosis in Kwilu Province, Democratic Republic of Congo. International Journal of Infectious Diseases, 110, 222-225.
[18]
Barry, M., Diallo, M.G., Diallo, S., Boiro, M.Y., Soumah, L., et al. (2023) Circulation du virus de l’hépatite B chez les donneurs de sang dans la Région de Mamou— République de Guinée. International Journal of Biological and Chemical Sciences, 17, 1180-1184.
[19]
Tonda, J., Mickala, P., Mombo, L., Mengue, J.E., Mongo-Délis, A., Mbacky, K., et al. (2017) Séroprévalence du virus de l’immunodéficience humaine, des virus des hépatites B et C et de Treponema pallidum chez les donneurs de sang dans une zone rurale au sud-est Gabon (Koula-Moutou). Journal of Applied Biosciences, 110, 10783-10789. https://doi.org/10.4314/jab.v110i1.8.
[20]
Samje, M., Sop, S., Tayou, C.T. and Mbanya, D. (2021) Knowledge, Attitude and Seropositivity of Hepatitis B Virus among Blood Donors in the Bamenda Regional Hospital Blood Bank, Cameroon. Pan African Medical Journal, 39, Article 33. https://doi.org/10.11604/pamj.2021.39.33.28911
[21]
Ankouane, F., et al. (2016) Séroprévalence des virus des hépatites B et C, du VIH-1/2 et de la syphilis chez les donneurs de sang de l’hôpital central de Yaoundé, région du centre, Cameroun. EM-Consulten. https://www.em-consulte.com/article/1062281/seroprevalence-des-virus-des-hepatitesb-et-c-du-v
[22]
Nouanthong, P., Hefele, L., Keokhamphue, J., Sorrasin, V., Khounvisith, V., Souksakhone, C., et al. (2021) Analyses of Blood Donor Samples from Eight Provinces in Lao PDR Suggest Considerable Variation Concerning HBV Exposure and Carriage. PLOS ONE, 16, e0259814. https://doi.org/10.1371/journal.pone.0259814
[23]
Institut National des Statistiques (INS) (2018) Enquete Demographique et de Santé (EDS V). https://www.unicef.org/guinea/media/2106/file/EDS%202018.pdf
[24]
Ahmed, R., Fatima, M., Ashfaq, J., Tariq, S.F., Naseer, I., Asif, M., et al. (2022) Frequency of Hepatitis B, C, and Human Immunodeficiency Virus in Blood Donors. Cureus, 14, e25978. https://doi.org/10.7759/cureus.25978
[25]
Keita, M., Fadiga, A.G., Soumah, M.M., Sylla, D., Traore, F.A., Biané, B., et al. (2014) Co-infection VIH et virus de l’hépatite B au service d’hématologie de l’hôpital national Ignace Deen (Guinée-Conakry). Annales de Dermatologie et de Vénéréologie, 141, S442. https://doi.org/10.1016/j.annder.2014.09.479
[26]
Bartonjo, G., Oundo, J. and Ng’ang’a, Z. (2019) Prevalence and Associated Risk Factors of Transfusion Transmissible Infections among Blood Donors at Regional Blood Transfusion Center Nakuru and Tenwek Mission Hospital, Kenya. Pan African Medical Journal, 34, Article 31. https://doi.org/10.11604/pamj.2019.34.31.17885
[27]
Tognon, F., Sevalie, S., Gassimu, J., Sesay, J., Hann, K., Sheku, M., et al. (2020) Seroprevalence of Hepatitis B and Hepatitis C among Blood Donors in Sierra Leone: A Multi-Year Retrospective Study. International Journal of Infectious Diseases, 99, 102-107. https://doi.org/10.1016/j.ijid.2020.07.030
[28]
Ouedraogo, H.G., Kouanda, S., Grosso, A., Compaoré, R., Camara, M., Dabire, C., et al. (2018) Hepatitis B, C, and D Virus and Human T-Cell Leukemia Virus Types 1 and 2 Infections and Correlates among Men Who Have Sex with Men in Ouagadougou, Burkina Faso. Virology Journal, 15, Article No. 194. https://doi.org/10.1186/s12985-018-1110-8
